IMNN
Income statement / Annual
Last year (2024), Imunon, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Imunon, Inc.'s net income was -$18.62 M.
See Imunon, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
$500.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
$500.00 K
|
| Gross Profit Ratio |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
| Research and Development Expenses |
$11.64 M
|
$11.29 M
|
$11.73 M
|
$10.62 M
|
$11.34 M
|
$13.07 M
|
$11.87 M
|
$13.08 M
|
$14.62 M
|
$14.66 M
|
| General & Administrative Expenses |
$7.49 M
|
$9.74 M
|
$13.69 M
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.49 M
|
$9.74 M
|
$13.69 M
|
$10.89 M
|
$7.64 M
|
$8.00 M
|
$9.70 M
|
$5.89 M
|
$6.53 M
|
$6.69 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$19.13 M
|
$21.03 M
|
$25.42 M
|
$21.51 M
|
$18.99 M
|
$21.07 M
|
$21.57 M
|
$18.97 M
|
$21.15 M
|
$21.35 M
|
| Cost And Expenses |
$19.13 M
|
$21.03 M
|
$25.42 M
|
$21.51 M
|
$18.99 M
|
$21.07 M
|
$21.57 M
|
$18.97 M
|
$21.15 M
|
$21.35 M
|
| Interest Income |
$450.22 K
|
$725.82 K
|
$502.58 K
|
$18.15 K
|
$66.55 K
|
$442.99 K
|
$363.85 K
|
$26.04 K
|
$31.26 K
|
$186.32 K
|
| Interest Expense |
$0.00
|
$197.08 K
|
$5.03 M
|
$569.88 K
|
$1.29 M
|
$1.39 M
|
$712.03 K
|
$91.76 K
|
$722.99 K
|
$1.36 M
|
| Depreciation & Amortization |
$718.12 K
|
$720.01 K
|
$731.63 K
|
$702.92 K
|
$741.52 K
|
$721.67 K
|
$356.86 K
|
$553.01 K
|
$1.02 M
|
$424.97 K
|
| EBITDA |
-$17.90 M |
-$19.88 M |
-$31.71 M |
-$20.88 M |
-$21.30 M |
-$16.55 M |
-$21.23 M |
-$19.76 M |
-$20.31 M |
-$20.68 M |
| EBITDA Ratio |
0
|
0
|
-63.41
|
-41.76
|
-42.59
|
-33.11
|
-42.47
|
-39.51
|
-40.62
|
-41.36
|
| Operating Income Ratio |
0
|
0
|
-49.84
|
-42.01
|
-36.97
|
-41.13
|
-42.13
|
-36.94
|
-41.3
|
-41.69
|
| Total Other Income/Expenses Net |
$512.20 K
|
$235.07 K
|
-$12.54 M
|
-$1.15 M
|
-$4.84 M
|
$1.90 M
|
-$1.24 M
|
-$1.93 M
|
-$1.40 M
|
-$1.61 M
|
| Income Before Tax |
-$18.62 M
|
-$20.80 M
|
-$37.47 M
|
-$22.15 M
|
-$23.33 M
|
-$18.67 M
|
-$22.30 M
|
-$20.40 M
|
-$22.05 M
|
-$22.46 M
|
| Income Before Tax Ratio |
0
|
0
|
-74.93
|
-44.31
|
-46.66
|
-37.34
|
-44.6
|
-40.8
|
-44.11
|
-44.92
|
| Income Tax Expense |
$0.00
|
-$1.28 M
|
-$1.57 M
|
-$1.38 M
|
-$1.85 M
|
-$1.82 M
|
-$10.42 M
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$18.62 M
|
-$19.51 M
|
-$35.90 M
|
-$20.77 M
|
-$21.48 M
|
-$16.85 M
|
-$11.88 M
|
-$20.40 M
|
-$22.05 M
|
-$22.46 M
|
| Net Income Ratio |
0
|
0
|
-71.8
|
-41.54
|
-42.97
|
-33.7
|
-23.77
|
-40.8
|
-44.11
|
-44.92
|
| EPS |
-21.1043 |
-28.1409 |
-65.5522 |
-748.7724 |
-131.5134 |
-151.0121 |
-132.2315 |
-532.2207 |
-2328.2603 |
-2821.3037 |
| EPS Diluted |
-21.1043 |
-28.1409 |
-65.5522 |
-748.7724 |
-131.5134 |
-151.0121 |
-132.2315 |
-532.2207 |
-2328.2603 |
-2821.3037 |
| Weighted Average Shares Out |
$882.29 K
|
$693.47 K
|
$547.63 K
|
$27.74 K
|
$163.36 K
|
$111.59 K
|
$89.87 K
|
$38.98 K
|
$9.48 K
|
$7.96 K
|
| Weighted Average Shares Out Diluted |
$882.29 K
|
$693.47 K
|
$547.63 K
|
$27.74 K
|
$163.36 K
|
$111.59 K
|
$89.87 K
|
$38.98 K
|
$9.48 K
|
$7.96 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
